Candidemia in the ICU: Does Initial Antifungal Matter?
作者信息
Bennett John E, Powers John H
机构信息
Laboratory of Clinical Immunology and Microbiology, NIAID, NIH, Bethesda, MD Clinical Monitoring Research Program, Leidos Biomedical Research, NCI Campus at Frederick, Frederick, MD.
出版信息
Crit Care Med. 2018 Mar;46(3):482-483. doi: 10.1097/CCM.0000000000002903.
Abstract
摘要
相似文献
1
Candidemia in the ICU: Does Initial Antifungal Matter?重症监护病房中的念珠菌血症：初始抗真菌治疗重要吗？
Crit Care Med. 2018 Mar;46(3):482-483. doi: 10.1097/CCM.0000000000002903.
2
Evaluation of first-line therapies for the treatment of candidemia in ICU patients: A propensity score analysis.评估 ICU 患者念珠菌血症一线治疗方案：倾向评分分析。
Int J Infect Dis. 2020 Apr;93:15-21. doi: 10.1016/j.ijid.2020.01.037. Epub 2020 Jan 23.
3
Evidence-based clinical standard for the diagnosis and treatment of candidemia in critically ill patients in the intensive care unit.重症监护病房危重症患者念珠菌血症诊断与治疗的循证临床标准
Braz J Infect Dis. 2025 Jan-Feb;29(1):104495. doi: 10.1016/j.bjid.2024.104495. Epub 2024 Dec 21.
4
Candidemia in non-neutropenic critically ill patients: analysis of prognostic factors and assessment of systemic antifungal therapy. Study Group of Fungal Infection in the ICU.非中性粒细胞减少的重症患者念珠菌血症：预后因素分析及全身抗真菌治疗评估。重症监护病房真菌感染研究组
Intensive Care Med. 1997 Jan;23(1):23-30. doi: 10.1007/s001340050286.
5
Candidemia in Adult Patients in the ICU: A Reappraisal of Susceptibility Testing and Antifungal Therapy.重症监护病房成年患者的念珠菌血症：药敏试验和抗真菌治疗的重新评估
Ann Pharmacother. 2024 Mar;58(3):305-321. doi: 10.1177/10600280231175201. Epub 2023 Jun 5.
6
Candidemia in the Intensive Care Unit.重症监护病房中的念珠菌血症
Clin Chest Med. 2017 Sep;38(3):493-509. doi: 10.1016/j.ccm.2017.04.010. Epub 2017 Jun 16.
7
Diagnosis and Treatment of Candidemia in the Intensive Care Unit.重症监护病房念珠菌血症的诊断与治疗。
Semin Respir Crit Care Med. 2019 Aug;40(4):524-539. doi: 10.1055/s-0039-1693704. Epub 2019 Oct 4.
8
Empiric antifungal and outcome in ICU patients.重症监护病房患者的经验性抗真菌治疗与治疗结果
Tunis Med. 2019 Apr;97(4):579-587.
9
Initial Antifungal Strategy Reduces Mortality in Critically Ill Patients With Candidemia: A Propensity Score-Adjusted Analysis of a Multicenter Study.初始抗真菌策略可降低念珠菌血症危重症患者的死亡率：一项多中心研究的倾向性评分调整分析。
Crit Care Med. 2018 Mar;46(3):384-393. doi: 10.1097/CCM.0000000000002867.
10
Candidemia and candiduria in critically ill patients admitted to intensive care units in France: incidence, molecular diversity, management and outcome.法国重症监护病房收治的危重症患者的念珠菌血症和念珠菌尿症：发病率、分子多样性、管理及预后
Intensive Care Med. 2008 Feb;34(2):292-9. doi: 10.1007/s00134-007-0865-y. Epub 2007 Oct 2.
引用本文的文献
1
Epidemiology, clinical characteristics, and outcome of candidemia in critically ill patients in Germany: a single-center retrospective 10-year analysis.德国重症患者念珠菌血症的流行病学、临床特征及转归：一项单中心10年回顾性分析
Ann Intensive Care. 2020 Oct 16;10(1):142. doi: 10.1186/s13613-020-00755-8.
本文引用的文献
1
Initial Antifungal Strategy Reduces Mortality in Critically Ill Patients With Candidemia: A Propensity Score-Adjusted Analysis of a Multicenter Study.初始抗真菌策略可降低念珠菌血症危重症患者的死亡率：一项多中心研究的倾向性评分调整分析。
Crit Care Med. 2018 Mar;46(3):384-393. doi: 10.1097/CCM.0000000000002867.
2
Impact of fluconazole susceptibility on the outcome of patients with candidaemia: data from a population-based surveillance.氟康唑药敏性对念珠菌血症患者结局的影响：基于人群监测的数据。
Clin Microbiol Infect. 2017 Sep;23(9):672.e1-672.e11. doi: 10.1016/j.cmi.2017.01.014. Epub 2017 Jan 29.
3
Empirical and targeted therapy of candidemia with fluconazole versus echinocandins: a propensity score-derived analysis of a population-based, multicentre prospective cohort.氟康唑与棘白菌素类药物治疗念珠菌血症的经验性和靶向治疗：基于人群、多中心前瞻性队列的倾向评分分析。
Clin Microbiol Infect. 2016 Aug;22(8):733.e1-8. doi: 10.1016/j.cmi.2016.05.008. Epub 2016 May 14.
4
Propensity Score Analysis of the Role of Initial Antifungal Therapy in the Outcome of Candida glabrata Bloodstream Infections.光滑念珠菌血流感染结局中初始抗真菌治疗作用的倾向评分分析
Antimicrob Agents Chemother. 2016 May 23;60(6):3291-300. doi: 10.1128/AAC.00195-16. Print 2016 Jun.
5
Initial antifungal strategy does not correlate with mortality in patients with candidemia.初始抗真菌策略与念珠菌血症患者的死亡率无关。
Eur J Clin Microbiol Infect Dis. 2016 Feb;35(2):187-93. doi: 10.1007/s10096-015-2527-2. Epub 2015 Dec 3.
6
Prognostic factors and historical trends in the epidemiology of candidemia in critically ill patients: an analysis of five multicenter studies sequentially conducted over a 9-year period.重症患者念珠菌血症流行病学的预后因素及历史趋势：对9年间相继开展的五项多中心研究的分析
Intensive Care Med. 2014 Oct;40(10):1489-98. doi: 10.1007/s00134-014-3400-y. Epub 2014 Aug 1.
7
A multicenter study of septic shock due to candidemia: outcomes and predictors of mortality.一项关于念珠菌血症导致的感染性休克的多中心研究：结局和死亡率的预测因素。
Intensive Care Med. 2014 Jun;40(6):839-45. doi: 10.1007/s00134-014-3310-z. Epub 2014 May 8.
8
Candidemia in the critically ill: initial therapy and outcome in mechanically ventilated patients.危重症患者的念珠菌血症：机械通气患者的初始治疗和结局。
BMC Anesthesiol. 2013 Oct 30;13(1):37. doi: 10.1186/1471-2253-13-37.
9
Fluconazole versus an echinocandin for Candida glabrata fungaemia: a retrospective cohort study.氟康唑与棘白菌素类药物治疗近平滑念珠菌菌血症的回顾性队列研究。
J Antimicrob Chemother. 2013 Apr;68(4):922-6. doi: 10.1093/jac/dks482. Epub 2012 Dec 4.
10
Assessment of candidemia-attributable mortality in critically ill patients using propensity score matching analysis.使用倾向评分匹配分析评估重症患者念珠菌血症归因死亡率。
Crit Care. 2012 Jun 14;16(3):R105. doi: 10.1186/cc11388.
Zotero 插件